The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Axura

5+10+15+20 milligram(s) Film-coated tablet

Merz Pharmaceuticals GmbHEU/1/02/218/16

Main Information

Trade NameAxura
Active SubstancesMemantine
Strength5+10+15+20 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMerz Pharmaceuticals GmbH
Licence NumberEU/1/02/218/16

Group Information

ATC CodeN06DX Other anti-dementia drugs
N06DX01 memantine

Status

Authorised/WithdrawnAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0022-106-003
Interchangeable List DocumentPDF of Interchangeable List
« Back